 GoLocalProv | NEW: EpiVax Gets $2.25M From National Institutes of Health GoLocalProv Also known as biotherapeutics, drugs such as Campath, Rituximab, enzyme replacement therapies such as Myozyme, and blood factors such as FVIII often induce antibodies, rendering the drugs less effective or ineffective. In addition, Tregitopes may have ... |
